
Arrowhead Pharmaceuticals Investor Relations Material
Latest events

Q1 2025
Arrowhead Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Arrowhead Pharmaceuticals Inc
Access all reports
Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for the treatment of intractable diseases in the United States. Its two platform technology includes a subcutaneous gene therapy program, which is focused on developing RNAi candidates targeting RNA sequences that are not amenable to conventional oral delivery through compacted, double-stranded RNA formulations for liver targeted delivery; and peptide platform technology that enables subcutaneous delivery of biologically active oligonucleotide payloads without the need for liposomal or polymeric encapsulation systems.
Key slides for Arrowhead Pharmaceuticals Inc


Status Update
Arrowhead Pharmaceuticals Inc


Status Update
Arrowhead Pharmaceuticals Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
ARWR
Country
🇺🇸 United States